Grants & Programs

Regulatory Guidance

The Consortium facilitates dialog with regulatory bodies, such as the U.S. Food and Drug Administration, in order to provide a comprehensive understanding of the regulatory climate and help develop needed standards for evaluating cancer immunotherapies.


Contact Us

Want to learn more about the Cancer Immunotherapy Consortium? Contact a CIC representative at or (212) 688-7515.